Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04347538 · ClinicalTrials.gov registry record · NA

Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19

A NA study of COVID-19, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
88
Enrollment target
1
Study location

NCT04347538 is a NA study of COVID-19 that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 88 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04347538, a NA study of COVID-19, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target
1
Study location

Study Summary

Nasal saline irrigations are a safe and commonly used mechanism to treat a variety of sinonasal diseases including sinusitis, rhinitis, and upper respiratory tract infections. When used properly, these irrigations are a safe and easy intervention available over the counter without a prescription. Additionally, baby shampoo has been found to be a safe additive functioning as a surfactant when a small amount is added to the saline rinses which may help augment clearance of the sinonasal cavity. While many systemic medications and treatments have been proposed for COVID-19, there has not yet been a study looking at targeted local intervention to the nasal cavity and nasopharynx where the viral load is the highest. Studies have shown that the use of simple over the counter nasal saline irrigations can decrease viral shedding in the setting of viral URIs, including the common coronavirus (not SARS-CoV-2). Further, as SARS-CoV-2 is an enveloped virus, mild-detergent application with nasal saline would neutralize the virus further. It is our hypothesis that nasal saline or nasal saline with baby shampoo irrigations may decrease viral shedding/viral load and viral transmission, secondary bacterial load, nasopharyngeal inflammation in patients infected with the novel SARS-CoV-2.

Conditions Studied

Interventions

  • OTHER Saline Nasal Irrigation
  • OTHER Saline with Baby Shampoo Nasal Irrigation

Study Locations (1)

Tennessee

  • Vanderblt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2020-05-01
Est. Completion 2022-03-16
Phase NA

What the Registry Record Tells You About NCT04347538

The ClinicalTrials.gov registry entry for NCT04347538 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Saline Nasal Irrigation is the first listed.

NCT04347538 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT04347538 about?

NCT04347538 is a clinical study titled "Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19". Nasal saline irrigations are a safe and commonly used mechanism to treat a variety of sinonasal diseases including sinusitis, rhinitis, and upper respiratory tract infections. When used properly, these irrigations are a safe and easy intervention available over the counter without a prescription. Ad...

What is the current status of trial NCT04347538?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2020-05-01. Estimated completion is 2022-03-16.

What conditions does trial NCT04347538 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT04347538?

The interventions under investigation include: Saline Nasal Irrigation (OTHER), Saline with Baby Shampoo Nasal Irrigation (OTHER).

Who is sponsoring clinical trial NCT04347538?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04347538 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.